116 related articles for article (PubMed ID: 27586584)
1. Prognostic significance of immunohistochemical epithelial-mesenchymal transition markers in skin melanoma patients.
Pieniazek M; Donizy P; Halon A; Leskiewicz M; Matkowski R
Biomark Med; 2016 Sep; 10(9):975-85. PubMed ID: 27586584
[TBL] [Abstract][Full Text] [Related]
2. Nucleoli cytomorphology in cutaneous melanoma cells - a new prognostic approach to an old concept.
Donizy P; Biecek P; Halon A; Maciejczyk A; Matkowski R
Diagn Pathol; 2017 Dec; 12(1):88. PubMed ID: 29284501
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
4. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.
Girotti MR; Fernández M; López JA; Camafeita E; Fernández EA; Albar JP; Benedetti LG; Valacco MP; Brekken RA; Podhajcer OL; Llera AS
J Invest Dermatol; 2011 Dec; 131(12):2438-47. PubMed ID: 21850018
[TBL] [Abstract][Full Text] [Related]
5. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
6. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
7. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
8. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
9. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
[TBL] [Abstract][Full Text] [Related]
10. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
11. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
Br J Dermatol; 2013 Sep; 169(3):618-28. PubMed ID: 23662813
[TBL] [Abstract][Full Text] [Related]
12. The role of SPARC expression in pancreatic cancer progression and patient survival.
Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
[TBL] [Abstract][Full Text] [Related]
13. Role of epithelial-mesenchymal transition involved molecules in the progression of cutaneous melanoma.
Murtas D; Maxia C; Diana A; Pilloni L; Corda C; Minerba L; Tomei S; Piras F; Ferreli C; Perra MT
Histochem Cell Biol; 2017 Dec; 148(6):639-649. PubMed ID: 28828681
[TBL] [Abstract][Full Text] [Related]
14. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract][Full Text] [Related]
15. Sarcomatoid renal cell carcinoma is an example of epithelial--mesenchymal transition.
Conant JL; Peng Z; Evans MF; Naud S; Cooper K
J Clin Pathol; 2011 Dec; 64(12):1088-92. PubMed ID: 22003062
[TBL] [Abstract][Full Text] [Related]
16. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
[TBL] [Abstract][Full Text] [Related]
17. A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.
Wouters J; Stas M; Govaere O; Barrette K; Dudek A; Vankelecom H; Haydu LE; Thompson JF; Scolyer RA; van den Oord JJ
Mod Pathol; 2014 Aug; 27(8):1088-100. PubMed ID: 24390218
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.
Bhandaru M; Martinka M; McElwee KJ; Rotte A
PLoS One; 2015; 10(8):e0134678. PubMed ID: 26275218
[TBL] [Abstract][Full Text] [Related]
19. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
20. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]